Brief: New Data From Banner University Medicine Demonstrating Effectiveness Of Bva-100® Use In Ambulatory Heart Failure Patients Presented At Heart Failure Society Of America Annual Scientific Meeting
11/10/2023 13:06
Oct 11 (Reuters) - Daxor Corp DXR.O :
* NEW DATA FROM BANNER UNIVERSITY MEDICINE DEMONSTRATING
EFFECTIVENESS OF BVA-100® USE IN AMBULATORY HEART FAILURE
PATIENTS PRESENTED AT HEART FAILURE SOCIETY OF AMERICA ANNUAL
SCIENTIFIC MEETING
Source text for Eikon: ID:nGNX2s5LJs
Further company coverage: DXR.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Daxor
See all newsNASDAQ RESUMED AT 02:03 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:58 PM
Brief: Daxor Corp Reaffirms Focus On Blood Volume Analysis Technology
Brief: Daxor Corporation Submits 510(K) To FDA For Next-Generation Blood Volume Analyzer
Brief: Daxor Corporation Streamlines Regulatory Strategy For Groundbreaking Diagnostic Device